Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

has developed a new biomaterial with high potential in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

Early treatment with intravenous bisphosphonates at first radiographic evidence of bone lesions in patients with solid tumors or evidence of osteopenia in patients with multiple myeloma can ...

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

More information: Raphael Lutz et al, Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma, Science Immunology (2025). DOI: 10.1126/sciimmunol ...

The team tackled a critical challenge in treating multiple myeloma—a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.